《Therapeutic Advances In Psychopharmacology》雜志的最新年發(fā)文量為33篇。
這表明該刊在每年都會(huì)精選并發(fā)表一定數(shù)量的高質(zhì)量文章，以保持其在藥學(xué)領(lǐng)域的學(xué)術(shù)影響力。
該刊聚焦于醫(yī)學(xué)-藥學(xué)領(lǐng)域的前沿研究，致力于推動(dòng)該領(lǐng)域新技術(shù)和新知識(shí)的傳播與應(yīng)用。同時(shí)它積極鼓勵(lì)研究人員詳細(xì)發(fā)表其高質(zhì)量的實(shí)驗(yàn)研究和理論成果。
該刊的平均審稿周期約為 10 Weeks 。
Therapeutic Advances In Psychopharmacology 雜志發(fā)文統(tǒng)計(jì)
文章名稱引用次數(shù)
- Epidemiology and risk factors for bipolar disorder35
- The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses21
- Genetic risk factors for eating disorders: an update and insights into pathophysiology15
- Medication nonadherence in bipolar disorder: a narrative review15
- Frontotemporal dementia: latest evidence and clinical implications13
- Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment12
- Real-world effectiveness of long-acting antipsychotic treatments in a nationwide cohort of 3957 patients with schizophrenia, schizoaffective disorder and other diagnoses in Quebec10
- Assessment and management of sexual dysfunction in the context of depression10
- Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation10
- Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression10
國(guó)家/地區(qū)發(fā)文量
- England54
- USA24
- Canada11
- Netherlands10
- Australia5
- Spain5
- Sweden5
- Brazil4
- GERMANY (FED REP GER)4
- Italy4
